drug
roginolisib
Phase 2updated 6mo agoby iOnctura SA
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying roginolisib
- phase2A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors
- phase2A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
- phase2A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
- phase2A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
News(1)
- Merck KGaA spinout iOnctura touts PI3K delta inhibitor in metastatic eye canceriOnctura’s PI3K delta inhibitor shows promise in phase 1 study in patients with mostly pre-treated metastatic melanoma.fiercebiotech · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that